Cynthia is a newborn ICU nurse by trade that has spent the last six years in the medical device industry educating nurses and doctors about devices that are new to their facility. In her spare time she enjoys hiking, traveling the world with her family, and creating Halloween animatronics for her annual front yard display. She has a passion for life-long learning and enjoys sharing what she learns with the people around her.

Dr. Kazandjian’s clinical and translational research interests lie in the treatment of precursor plasma cell disorders including high risk smoldering multiple myeloma and the role of immunotherapy in plasma cell dyscrasias. In addition, he is re-evaluating the role of autologous stem cell transplant (ASCT) in the era of highly efficacious novel-novel drugs, immunotherapy biologics, and cell-based therapies with the hypothesis that certain subsets of patients with myeloma may not benefit by default upfront ASCT.

Kellye Koubek is an Advanced Practice Registered Nurse at the University of Miami’s Sylvester Comprehensive Cancer Center.  After graduating in 2011 with a Bachelor of Science in Nursing from Xavier University, Kellye Koubek gained valuable experience working as a registered nurse in various hospital platforms. She then pursued a Master of Science from Hunter College in New York City, graduating in 2021 from Hunter’s Adult-Gerontology Primary Care Nurse Practitioner program. Her commitment to advancing oncology research is underscored by her prior experience as a Clinical Trial Nurse at Memorial Sloan Kettering Cancer Center. Currently, Kellye serves as a Research Advanced Practice Nurse at the Sylvester Myeloma Institute, specializing in plasma cell disorders. Beyond her clinical duties, Kellye actively contributes to the advancement of medical science by serving as a sub-investigator for interventional clinical trials, playing a crucial role in the implementation and development of research trials, and facilitating the dissemination of clinical trial findings.